Has John Martin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,456 in general payments to John Martin, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Martin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Martin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Martin, MD

Gastroenterology · Rochester, MNNPI 1609808534

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,022 of the $12,456 with a category attached, or 72.4%. Olympus Corporation Of The Americas accounts for 70.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $8,902 and has fallen 99.3% since, to $59 in 2025.

$12,456in general payments, 2019–2025

Across 35 payments — averaging $355.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Olympus Corporation Of The Americas$9K
Olympus Corporation$2K
Boston Scientific$982
Olympus America Inc.$225
Micro-tech Endoscopy USA, Inc.$78

What the payments were for

Consulting fees$9,02272%
Travel & lodging$2,07717%
Food & beverage$1,35711%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Olympus Corporation Of The Americas	20	$8,822
Olympus Corporation	4	$2,349
Boston Scientific	8	$982
Olympus America Inc.	2	$225
Micro-tech Endoscopy USA, Inc.	1	$78

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,456 in reported general payments places this provider in the 85th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$89,574

Medicare patients

211

Services billed

532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levofloxacin	42	$97

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rochester

John KisielRochester$856K
Christopher GostoutRochester$299K
Edward LoftusRochester$282K
Alina AllenRochester$277K
Todd BaronRochester$270K
Sahil KhannaRochester$242K
Joseph MurrayRochester$234K
Andres AcostaRochester$224K
David LarsonRochester$142K
Ibrahim HanounehRochester$104K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →